<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8811625</journal-id><journal-id journal-id-type="pubmed-jr-id">5250</journal-id><journal-id journal-id-type="nlm-ta">J Hum Hypertens</journal-id><journal-id journal-id-type="iso-abbrev">J Hum Hypertens</journal-id><journal-title-group><journal-title>Journal of human hypertension</journal-title></journal-title-group><issn pub-type="ppub">0950-9240</issn><issn pub-type="epub">1476-5527</issn></journal-meta><article-meta><article-id pub-id-type="pmid">19626043</article-id><article-id pub-id-type="pmc">2841705</article-id><article-id pub-id-type="doi">10.1038/jhh.2009.58</article-id><article-id pub-id-type="manuscript">NIHMS111567</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>DASH Lowers Blood Pressure in Obese Hypertensives Beyond Potassium, Magnesium and Fiber</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Al-Solaiman</surname><given-names>Yaser</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Jesri</surname><given-names>Ammar</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Mountford</surname><given-names>William K.</given-names></name><degrees>PhD</degrees></contrib><contrib contrib-type="author"><name><surname>Lackland</surname><given-names>Daniel T.</given-names></name><degrees>DrPH</degrees></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yumin</given-names></name><degrees>DMSc</degrees></contrib><contrib contrib-type="author"><name><surname>Egan</surname><given-names>Brent M.</given-names></name><degrees>MD</degrees></contrib><aff id="A1">
Department of Medicine Medical University of South Carolina, Charleston, SC
</aff></contrib-group><author-notes><corresp id="CR1"><underline>Address for correspondence and reprint requests</underline>: Brent M. Egan, MD Department of Medicine, MUSC 135 Rutledge Avenue, RT 1230 Charleston, SC 29425 e-mail: <email>eganbm@musc.edu</email> Telephone: (843)-792-1715 Facsimile: (843)-792-0816
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>21</day><month>4</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>7</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>10</month><year>2010</year></pub-date><volume>24</volume><issue>4</issue><fpage>237</fpage><lpage>246</lpage><!--elocation-id from pubmed: 10.1038/jhh.2009.58--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><p id="P1">The mechanism underlying blood pressure reduction in the high fruits and vegetables arm of the Dietary Approaches to Stop Hypertension (DASH) Study is unknown but may include potassium, magnesium and fiber. This study was designed to separate minerals and fiber from other components of DASH on blood pressure in abdominally obese metabolic syndrome subjects with prehypertension to Stage 1 hypertension (obese hypertensives). Fifteen obese hypertensives and 15 lean normotensives were studied on a standardized usual diet, randomized to DASH or usual diet supplemented with potassium, magnesium and fiber to match DASH, then crossed over to the complementary diet. All diets were three weeks long, isocaloric and matched for sodium and calcium. In obese hypertensives, blood pressure was lower after 3 weeks on DASH than usual diet (-7.6&#x000b1;1.4/-5.3&#x000b1;1.4 mmHg, p&#x0003c;0.001/0.02 and usual diet supplemented (-6.2&#x000b1;1.4/-3.7&#x000b1;1.4 p&#x0003c;0.005/0.06), whereas blood pressure was not significantly different on usual and supplemented diets. Blood pressure values were not different among the three diets in lean normotensives. Small artery elasticity was lower in obese hypertensives than lean normotensives on the usual and supplemented diets (p&#x0003c;0.02). This index of endothelial function improved in obese hypertensives (p&#x0003c;0.02) but not lean normotensives on DASH and was no longer different from values in lean normotensives (p&#x0003e;0.50). DASH is more effective than potassium, magnesium, and fiber supplements for lowering blood pressure in obese hypertensives, which suggest that high fruits and vegetables DASH lowers blood pressure and improves endothelial function in this group by nutritional factors in addition to potassium, magnesium and fiber.</p></abstract><kwd-group><kwd>Blood pressure</kwd><kwd>Dietary Approaches to Stop Hypertension (DASH)</kwd><kwd>obesity hypertension</kwd><kwd>metabolic syndrome</kwd><kwd>potassium</kwd><kwd>magnesium</kwd><kwd>fiber</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>INTRODUCTION</title><p id="P2">The majority of pre-hypertensive and hypertensive patients are overweight or obese.<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref> A substantial minority of pre-hypertensive and the majority of hypertensive patients have the metabolic syndrome.<xref rid="R3" ref-type="bibr">3</xref> Weight loss ameliorates several facets of the metabolic syndrome including elevated blood pressure,<xref rid="R4" ref-type="bibr">4</xref> yet sustained weight loss is an elusive long-term end-point for most obese people.<xref rid="R5" ref-type="bibr">5</xref> Lifestyle interventions that reduce risk without weight loss could be useful in managing metabolic syndrome related risk and disease.</p><p id="P3">The Dietary Approaches to Stop Hypertension (DASH) Eating Plan, which is rich in fruits and vegetables, lowers blood pressure and improves the lipid profile without weight loss in hypertensive subjects.<xref rid="R6" ref-type="bibr">6</xref> While DASH lowered blood pressure more with than without low fat dairy products, both diets reduced blood pressure in hypertensive patients. Both diets are high in potassium, magnesium, and fiber, which are associated with reduction of blood pressure.<xref rid="R7" ref-type="bibr">7</xref>-<xref rid="R9" ref-type="bibr">9</xref></p><p id="P4">Obesity and the metabolic syndrome are linked to inflammation and oxidative stress, which contribute to endothelial dysfunction.<xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R12" ref-type="bibr">12</xref> Endothelial dysfunction is implicated in the pathophysiology of hypertension and cardiovascular disease.<xref rid="R13" ref-type="bibr">13</xref> The fruits, vegetables and other whole foods in DASH contain numerous flavonoids and antioxidants, which may reduce oxidative stress, improve endothelial function and lower blood pressure.<xref rid="R14" ref-type="bibr">14</xref> The high potassium, magnesium and fiber content of DASH may also improve endothelial and vascular function.<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></p><p id="P5">Our study was designed to separate the effects of minerals and fiber from other components of DASH on blood pressure and markers of endothelial and vascular function in abdominally obese pre-hypertensive and hypertensive patients with the metabolic syndrome. Lean normotensive subjects without metabolic syndrome risk factors were studied as a healthy, time-control group. The comparators included a standardized typical Western diet, which is low in fruits, vegetables and other whole foods, the usual diet supplemented with potassium, magnesium, and fiber to match DASH, and DASH fruits and vegetables without emphasis on low fat dairy products given relatively poor adoption by free-living volunteers in our previous study.<xref rid="R14" ref-type="bibr">14</xref> The diets were isocaloric and matched for sodium and calcium.</p></sec><sec sec-type="methods" id="S2"><title>METHODS</title><sec id="S3"><title>Ethics</title><p id="P6">The protocol was reviewed and approved by the Office of Research Protection and Integrity at the Medical University of South Carolina (MUSC). Paid study volunteers were recruited from the staff and clinics at MUSC. Written informed consent was obtained from all volunteers prior to the screening evaluation.</p></sec><sec sec-type="subjects" id="S4"><title>Subjects</title><p id="P7">Volunteers were recruited and studied from 2003&#x02013;2006. Inclusion criteria for lean normotensives were age 21&#x02013;49 years, body mass index &#x0003c;25 kg/m<sup>2</sup>, waist circumference &#x0003c;40 inches for men and &#x0003c;35 inches for women, blood pressure consistently &#x0003c;130/85 mmHg on all 3 visits prior to the first study, fasting glucose &#x0003c;100 mg/dl, fasting triglycerides &#x0003c;125 mg/dl, HDL-cholesterol &#x02265;40 mg/dl for men and &#x02265;45mg/dl for women, total cholesterol &#x0003c;200 mg/dl and/or total cholesterol / HDL &#x02264;3.5.</p><p id="P8">Inclusion criteria for abdominally obese patients included blood pressure 130&#x02013;159/85&#x02013;99 mmHg on the three screening visits, age 21&#x02013;49 years, waist circumference &#x0003e;40 inches in men and &#x0003e;35 inches for women, and at least one other metabolic syndrome criterion (impaired fasting glucose [100&#x02013;125 mg/dL], fasting triglycerides &#x02265;150 mg/dl or HDL-cholesterol &#x0003c;50 for women and &#x0003c;40 for men).<xref rid="R17" ref-type="bibr">17</xref></p><p id="P9">Exclusion criteria were diabetes mellitus (fasting glucose &#x02265;126 mg/dl or treatment), clinically evident target organ, or history of stroke, transient ischemic attack, myocardial infarction, angina pectoris, or chronic heart failure.</p><p id="P10">Volunteers discontinued all non-essential prescription and non-prescription medications and supplements at least 3 weeks before beginning the study. Patients requiring medications to maintain BP &#x0003c;160/&#x0003c;100 mmHg were excluded. Medications, which volunteers identified as essential and that were determined to have minimal effects on blood pressure, were allowed. Examples include antihistamines for allergies, H<sub>2</sub>-receptor blockers and proton pump inhibitors for gastroesophageal reflux, and selective serotonin reuptake inhibitors for depression. Acetaminophen was allowed; non-steroidal anti-inflammatory medications were not.</p></sec><sec id="S5"><title>Study diets</title><p id="P11">Subjects were studied first after 3 weeks on a standardized usual diet, with an average of one fruit and one vegetable (ULFV), &#x0223c;1700 mg potassium, 250 mg magnesium and 11 grams of fiber daily. They were randomized to ULFV supplemented with potassium, magnesium and fiber (ULFV-S) to match DASH, or DASH itself. Subjects completed the complementary phase of the randomized diet for three weeks. DASH without additional low-fat dairy was selected based on our prior study in free-living volunteers.<xref rid="R14" ref-type="bibr">14</xref></p><p id="P12">The nutrient targets for the three diets were &#x0223c;50% carbohydrate, 35% fat, and 15% protein with 3000 mg sodium and 700 mg calcium daily. The calcium target was within the range attained in our previous study of the DASH combination diet in lean and obese volunteers.<xref rid="R14" ref-type="bibr">14</xref> The ULFV diet was supplemented with potassium citrate (Upsher Smith Laboratories, Maple Grove, MN), or potassium chloride (Tower Laboratories Ltd., depending upon tolerability as both have similar blood pressure effects.<xref rid="R5" ref-type="bibr">5</xref> Diets were also supplemented with magnesium oxide (Goldline Lab, Mason, OH) Centerbrook, CT) and (Metamucil&#x000ae;, Procter &#x00026; Gamble, Cincinnati, OH) to match intake on DASH. The dietary potassium goal reflects levels achieved with fruits and vegetables DASH.<xref rid="R7" ref-type="bibr">7</xref> The Minnesota Nutrition Data Systems (Nutrition Coordinating Center, Minneapolis, MN) was used to analyze food records and pictures and estimate nutrient intake.<xref rid="R18" ref-type="bibr">18</xref></p><p id="P13">Study participants met individually with the GCRC dietician each week of the study. Sample menus of the ULFV and DASH were provided. Each subject&#x02019;s isocaloric energy intake was estimated using the Harris Benedict equation.<xref rid="R19" ref-type="bibr">19</xref> Volunteers kept a food diary and received a digital camera (PenCam VR, Aiptek, Irvine, to photograph all food and beverages consumed for 3 days before weekly visits with the dietician. Subjects collected weekly 24-hour urines for sodium and potassium. The dietician provided advice to further enhance dietary compliance and estimated nutrient consumption and dietary compliance from 3-day food records and urine data supplemented by photographs of food and beverages consumed.<xref rid="R20" ref-type="bibr">20</xref> Calories were adjusted weekly to minimize weight changes.</p></sec><sec id="S6"><title>Hemodynamic measurements</title><p id="P14">Blood pressure was measured with a random-zero sphygmomanometer, while participants were seated at three screening visits and weekly during the first two weeks of the three study diets. After three weeks on each diet, six supine (basal) BP readings were obtained with the random-zero device at 10-minute intervals.</p><p id="P15">Small and large artery elasticity were derived using the H.D.I./Pulse Wave CR-2000 (Eagan, MN).<xref rid="R21" ref-type="bibr">21</xref> Central (aortic) blood pressure was derived with the Sphygmacor (SCOR&#x02014;MX, West Ryde, NSW Australia).<xref rid="R22" ref-type="bibr">22</xref> Aortic augmentation index was calculated.<xref rid="R22" ref-type="bibr">22</xref></p></sec><sec id="S7"><title>Metabolic assays</title><p id="P16">Plasma insulin was measured by radioimmunoassay.<xref rid="R23" ref-type="bibr">23</xref> Homeostatic model assessment of insulin resistance (HOMAir) index was calculated.<xref rid="R24" ref-type="bibr">24</xref> Triglycerides, total and HDL-cholesterol were measured;<xref rid="R25" ref-type="bibr">25</xref> LDL-cholesterol was calculated.<xref rid="R26" ref-type="bibr">26</xref></p></sec><sec id="S8"><title>Study design and protocol</title><p id="P17">After 3 weeks on ULFV, subjects were randomized to DASH or the ULFV-S for the next 3 weeks. Volunteers crossed over to the complementary diet for 3 additional weeks. The dietary phases were not separated by a washout.</p><p id="P18">At the end of each 3-week dietary period, subjects were admitted to the outpatient GCRC at 8:00 AM after an overnight fast. Intravenous access was established. Supine hemodynamic data were obtained at 10 minute intervals for 60 minutes. Blood was then drawn for serum lipids, plasma glucose and plasma insulin.</p></sec><sec id="S9"><title>Statistical considerations</title><sec id="S10"><title>Sample size estimates</title><p id="P19">The primary outcome variable was the last four of six supine laboratory blood pressures taken after three weeks on each diet. With 15 subjects, the study had a power of greater than 90% (&#x003b2;&#x0003c;0.10) to detect the pre-specified 5 mmHg (&#x000b1; 10 mmHg variance) difference in systolic BP between diets within group at p&#x02264;0.05.</p></sec><sec id="S11"><title>Data analysis</title><p id="P20">Group comparisons for categorical variables, e.g., gender and ethnicity, were made using Chi-square tests. Data for continuous variables are presented as mean &#x000b1; standard error. For baseline variables such as age, nutrient intake, and blood pressure, two-sample t-tests were used to compare obese and lean groups. One-sample t-tests were used to assess changes in nutritional variables between DASH and ULFV-S in obese hypertensives. Changes in blood pressure, nutritional and biochemical measurements across the three dietary phases within and between groups were made using linear mixed models for repeated measures. An order effect of diet order on blood pressure was examined by Grizzle&#x02019;s method. Statistical analyses were performed with SAS Version 9.1. All statistical tests were two-sided, and p-values &#x0003c;0.05 were accepted as significant except Grizzle&#x02019;s method where a p-value &#x0003c;0.10 indicates an order effect.</p></sec></sec></sec><sec sec-type="results" id="S12"><title>Results</title><sec id="S13"><title>Study volunteers</title><p id="P21">As shown, 102 volunteers, including 36 lean and 66 obese subjects, completed the baseline history, physical, and laboratory assessment (<xref ref-type="fig" rid="F1">Figure 1</xref>). Sixty-five subjects did not qualify (screen failures), including 18 of 36 lean (50%) and 47 of 66 (71%) obese. Lean volunteers were generally excluded for having metabolic syndrome risk factors and obese subjects for having fewer than three. Of 102 volunteers screened, 37 qualified including 18 lean and 19 obese. Fifteen subjects in each group completed the three study phases and were included in the analysis.</p><p id="P22">Age, gender, and race were not different between the two groups (<xref ref-type="table" rid="T1">Table 1</xref>). Obese hypertensives had higher values than lean normotensives for blood pressure, body mass index, abdominal and hip circumferences, triglycerides, fasting glucose, and uric acid.</p></sec><sec id="S14"><title>Nutritional content of the diets</title><p id="P23">Fruits and vegetable on the usual and supplemented diet were lower than DASH (<xref ref-type="table" rid="T2">Table 2</xref>). Sodium intake was comparable across the three diets, while potassium, magnesium, and fiber were greater on ULFV-S and DASH than the baseline phase. Calcium intake was not different among the three dietary periods in lean normotensives or obese hypertensives, although mean values tended to be higher in obese hypertensives on DASH.</p></sec><sec id="S15"><title>Nutrient differences between ULFV-S and DASH in obese hypertensives</title><p id="P24">Estimated intake of arginine, lycopene, Vitamins C and alpha E, and folate were higher on DASH than ULFV-S. Soluble fiber intake was higher during ULFV-S than DASH, whereas insoluble fiber was higher on DASH than ULFV-S. Trans-fatty acid intake was lower on DASH than ULFV-S. Values for fish oils (docosohexanoic, eicosopentanoic), linolenic acid, sodium, potassium, calcium, magnesium and selenium were not different between the two diets.</p></sec><sec id="S16"><title>BP responses to dietary intervention</title><p id="P25">Peripheral (brachial) and estimated <italic>central</italic> (aortic) systolic and diastolic pressure at the end of 3 weeks on each diet are shown for obese hypertensives and lean normotensives in <xref ref-type="fig" rid="F2">Figure 2</xref>. Systolic and diastolic pressures were lower in obese subjects after 3 weeks on DASH than either ULFV or ULFV-S. BPs were not different between ULFV and ULFV-S in the obese group. Central systolic and diastolic pressures were also lower in obese subjects on DASH than ULFV but were not significantly different from ULFV-S. Brachial and central systolic and diastolic blood pressures were not different among the three dietary periods in lean volunteers. Blood pressure differences between the dietary periods for both groups are shown in <xref ref-type="fig" rid="F3">Figure 3</xref>.</p><p id="P26">Using Grizzle&#x02019;s method, no carry over effect was found of diet sequence on systolic BP in lean normotensives (p=0.42), obese hypertensives (p=0.73) or all subjects (p=0.89). Corresponding p-values for diastolic pressure were 0.08 (lean), 0.87 and 0.83.</p></sec><sec id="S17"><title>Vascular function</title><p id="P27">Nutritional effects on vascular stiffness were assessed with small and large artery elasticity and aortic augmentation index. Small and large artery elasticity values in obese hypertensives were higher on DASH than the other two diets, whereas values did not change significantly in lean normotensives. The aortic augmentation index was lower (improved) in both groups on DASH than ULFV-S. In obese hypertensives, this index was also lower on ULFV-S than the usual diet (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p></sec><sec id="S18"><title>Metabolic variables</title><p id="P28">Weight, heart rate, metabolic and urine electrolyte values are shown for lean and obese volunteers during the three dietary periods (<xref ref-type="table" rid="T4">Table 4</xref>). The only significant changes occurred in urine potassium and magnesium, which were higher on DASH and ULFV-S than the usual diet (ULFV). No significant differences were observed for any of the variables in <xref ref-type="table" rid="T4">Table 4</xref> between DASH and ULFV-S in either lean normotensives or obese hypertensives.</p></sec></sec><sec sec-type="discussion" id="S19"><title>Discussion</title><p id="P29">Abdominally obese subjects with the metabolic syndrome and (pre)hypertension had lower blood pressure on the DASH high fruits and vegetables eating plan than a usual diet low in fruits and vegetables ([ULFV] Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>). Blood pressure was also lower on DASH than ULFV supplemented with potassium, magnesium and fiber (ULFV-S) to match DASH. In contrast, blood pressure was not lower in obese hypertensives on ULFV-S than ULFV (<xref ref-type="table" rid="T3">Table 3</xref>).</p><p id="P30">Previous work raised the possibility that the high content of potassium, magnesium, and fiber in the DASH Eating Plan explains the beneficial blood pressure effects.<xref rid="R7" ref-type="bibr">7</xref>-<xref rid="R9" ref-type="bibr">9</xref> Other studies suggest these minerals and fiber may not fully account for the blood pressure effects of DASH.<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R16" ref-type="bibr">16</xref> This study was designed to separate the effects of minerals and fiber from other components of DASH which may include antioxidants and flavonoids,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref> on blood pressure and markers of endothelial and vascular function. The findings suggest DASH lowers blood pressure beyond the content of potassium, magnesium and fiber in abdominally obese (pre)hypertensives.</p><p id="P31">Sodium can have important blood pressure effects.<xref rid="R29" ref-type="bibr">29</xref> While controversial,<xref rid="R30" ref-type="bibr">30</xref> calcium may have modest BP effects.<xref rid="R31" ref-type="bibr">31</xref> Sodium intake was similar across the dietary periods, although somewhat lower than a typical Western diet. The moderate sodium restriction may have limited the effects of the supplements on blood pressure, especially potassium, which has natriuretic properties.<xref rid="R7" ref-type="bibr">7</xref> Mean calcium intake was &#x0223c;140 mg/d higher on DASH than ULFV-S (p=0.07). Based on previous studies on the blood pressure effects of calcium, this modest difference is unlikely to explain the lower blood pressure on DASH.<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R31" ref-type="bibr">31</xref></p><p id="P32">One meta-analysis found that supplemental fiber lowered blood pressure &#x0223c;1.1&#x02013;1.3 mmHg and reported soluble and mixed fiber lowers blood pressure, whereas insoluble fiber does not.<xref rid="R9" ref-type="bibr">9</xref> Soluble fiber intake was higher during ULFV-S than DASH. Thus, it is unlikely the greater blood pressure reduction with DASH than ULFV-S is explained by fiber composition.</p><p id="P33">Among obese hypertensives, DASH improved small artery elasticity (<xref ref-type="fig" rid="F4">Figure 4</xref>). Small artery elasticity serves as an index of endothelial function.<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref> The link between small artery elasticity and endothelial function is consistent with evidence that raising fatty acids systemically<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R33" ref-type="bibr">33</xref> that inhibit endothelial cell nitric oxide synthase and induce reactive oxygen species in vitro,<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref> impaired small artery elasticity in vivo. Our findings suggest nutritional components of DASH other than potassium, magnesium, sodium, calcium and fiber improved endothelial function in obese hypertensives.</p><p id="P34">Stiffness of the vascular system predicts adverse outcomes independently of blood pressure.<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref> DASH improved small and large distensibility and reduced the aortic augmentation index, a general measure of arterial system stiffness in obese hypertensives. DASH improved the augmentation index in lean subjects, despite a non-significant blood pressure effect. These findings are consistent with evidence that DASH-like eating patterns improve cardiovascular outcomes<xref rid="R38" ref-type="bibr">38</xref> and raise the possibility that beneficial effects on arterial function may contribute. Supplements improved the aortic augmentation index in obese hypertensives, which aligns with evidence that dietary potassium, magnesium and fiber are linked to better vascular outcomes.<xref rid="R39" ref-type="bibr">39</xref>-<xref rid="R41" ref-type="bibr">41</xref></p><p id="P35">Extensive efforts were made to estimate intake of nutrients, which could explain the observed effects on blood pressure and markers of endothelial and vascular function in the obese subjects. Arginine, lycopene, Vitamins C and E, and folate intake were all higher on DASH than ULFV-S (<xref ref-type="table" rid="T3">Table 3</xref>) and may have contributed to beneficial effects of DASH in obese volunteers with DASH. In contrast, intake of, selenium, caffeine, and omega-3 fatty acids (linolenic, eicosapentanoic and docosahexanoic), which may affect BP, were not different.<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R42" ref-type="bibr">42</xref></p><p id="P36">In obese subjects, blood pressure and indices of vascular function were more favorable on DASH than the control diet supplemented with potassium, magnesium and fiber to match DASH. It may be useful to examine nutritional differences between the two diets which could explain beneficial effects of DASH. Intake of arginine, the precursor for nitric oxide, was higher in obese hypertensives on DASH than ULFV-S. Arginine improves endothelium-dependent vasodilation and small artery elasticity.<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R44" ref-type="bibr">44</xref> and lowers blood pressure<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R45" ref-type="bibr">45</xref> Lycopene intake was also greater in obese subjects on DASH than ULFV-S, and may have lowered blood pressure.<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R46" ref-type="bibr">46</xref></p><p id="P37">Vitamins C intake was higher on DASH than ULFV-S. Vitamin C lowers blood pressure<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R47" ref-type="bibr">47</xref> and improves endothelial function, especially when a deficiency exists.<xref rid="R26" ref-type="bibr">26</xref> Vitamin C may lower blood pressure by enhancing nitric oxide synthase activity.<xref rid="R48" ref-type="bibr">48</xref> Vitamin C and E supplements in rats markedly attenuated glutathione deficiency-induced hypertension.<xref rid="R49" ref-type="bibr">49</xref> Vitamin C and E reduced arterial stiffness and improved endothelial function in hypertensives.<xref rid="R50" ref-type="bibr">50</xref> Vitamins C and E may lower blood pressure by scavenging reactive oxygen species, down-regulating NADPH oxidase, and increasing nitric oxide synthase.<xref rid="R50" ref-type="bibr">50</xref>,<xref rid="R51" ref-type="bibr">51</xref> Yet, Vitamin C and grape-seed polyphenols together<xref rid="R46" ref-type="bibr">46</xref> or alpha-tocopherol alone can raise blood pressure.<xref rid="R52" ref-type="bibr">52</xref></p><p id="P38">Estimated folate consumption was greater on DASH than ULFV-S. Studies suggest folate lowers blood pressure,<xref rid="R53" ref-type="bibr">53</xref>,<xref rid="R54" ref-type="bibr">54</xref> reduces hypertension incidence,<xref rid="R55" ref-type="bibr">55</xref> and improves endothelial function.<xref rid="R56" ref-type="bibr">56</xref>,<xref rid="R57" ref-type="bibr">57</xref> Several studies cited above indicate specific components of DASH, other than potassium, magnesium and fiber, lower blood pressure and improve endothelial function. DASH could also reduce consumption of factors such as refined sugar, which may raise blood pressure.</p><sec id="S20"><title>Limitations</title><p id="P39">Volunteers prepared their own meals, which may have compromised adherence in contrast to DASH, in which volunteers received food and beverages from a metabolic kitchen. The weekly three-day food records, photographs and timed urine collections suggested good adherence. Moreover, our data in free-living volunteers may be more applicable to patients in community-based clinical settings than metabolic feeding studies.</p><p id="P40">The dietary interventions were three weeks long and not separated by washout periods. The DASH report and our experience<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref> indicated that most of the blood pressure effect occurred within 2&#x02013;3 weeks. An order effect was not observed in our previous or current study.<xref rid="R14" ref-type="bibr">14</xref> The dietary interventions were unblinded. Thus, patient and investigator expectations may have influenced results. To minimize investigator bias, a random zero sphygmomanometer was used to measure blood pressure, the primary outcome variable. The limited effect of the supplemented diet on blood pressure may be partially due to the comparatively low sodium intake of &#x0223c;3000 mg daily. In our previous work, despite numerous prompts from the study dietician, free-living volunteers continued to consume significantly less than one low-fat dairy product daily. Thus, this study examined only the high fruits and vegetables DASH, and we cannot extrapolate our results to the combination diet.</p><p id="P41">We studied lean normotensives without and obese pre-hypertensives and hypertensives with the metabolic syndrome and cannot extrapolate beyond the groups studied. However, we believe the study findings are important, since obese, metabolic syndrome subjects comprise a large proportion of all patients with pre-hypertension and hypertension. Compared to the control diet, blood pressure effects of high fruits and vegetables DASH in our study are comparable to the original report.<xref rid="R6" ref-type="bibr">6</xref> Specifically, blood pressure changes in the current study and DASH fruits and vegetables were -2.0/-1.3 (lean normtensives [current]) vs. -0.8/-0.3 (non-hypertensives [DASH]) and -7.6/-5.3 (obese hypertensives [current]) vs. -7.2/-2.8 (hypertensives [DASH]). We cannot exclude the possibility that the potassium, magnesium and fiber contents of food in the high fruits and vegetables eating plan lower blood pressure by interacting with other nutrients in the high fruits and vegetables eating plan.<xref rid="R14" ref-type="bibr">14</xref></p><p id="P42">Our study shows that the DASH fruits and vegetables eating plan lowers blood pressure in obese, pre-hypertensive and hypertensive patients with the metabolic syndrome. Moreover, DASH improved their endothelial function and reduced vascular stiffness. The beneficial effects were less evident in obese subjects when a usual diet was supplemented with potassium, magnesium and fiber to match DASH. The data suggest DASH lowers blood pressure and improves endothelial function in obese, metabolic syndrome subjects with elevated blood pressure beyond potassium, magnesium and fiber.</p></sec></sec></body><back><ack id="S21"><title>Acknowledgements</title><p>The authors thank Kelley Martin, RD, MS, General Clinical Research Nutritionist, for her extraordinary efforts in assisting volunteers to comply with the study diets. We also thank the entire General Clinical Research Center staff for their dedication to the integrity of the research protocol as well as Kim Edwards for administrative support.</p><p>This research was supported by grants from the National Institutes of Health (HL58794, HL04290), MD00267 from the National Center for Minority Health and Disparities, and the General Clinical Research Center (RR-01070) from the Division of Research Resources.</p></ack><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Carroll</surname><given-names>MD</given-names></name><name><surname>Ogden</surname><given-names>CL</given-names></name><name><surname>Johnson</surname><given-names>CL</given-names></name></person-group>
<article-title>Prevalence and trends in obesity among US adults, 1999 &#x02013; 2000</article-title>
<source>JAMA</source>
<year>2002</year>
<volume>288</volume>
<fpage>1723</fpage>
<lpage>1727</lpage>
<pub-id pub-id-type="pmid">12365955</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q-J</given-names></name></person-group>
<article-title>The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: New challenges of the old problem</article-title>
<source>Arch Intern Med</source>
<year>2004</year>
<volume>164</volume>
<fpage>2126</fpage>
<lpage>2134</lpage>
<pub-id pub-id-type="pmid">15505126</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Egan</surname><given-names>BM</given-names></name></person-group>
<person-group person-group-type="editor"><name><surname>Bakris</surname><given-names>GL</given-names></name></person-group>
<article-title>Should metabolic syndrome patients with pre-hypertension receive antihypertensive therapy?</article-title>
<source>Therapeutic Strategies in Hypertension</source>
<year>2006</year>
<fpage>9</fpage>
<lpage>25</lpage>
<publisher-name>Clin Publ</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
<comment>ch 2</comment>
</element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Case</surname><given-names>CC</given-names></name><name><surname>Jones</surname><given-names>PH</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>E O&#x02019;Brian</given-names></name><name><surname>Ballantyne</surname><given-names>CM</given-names></name></person-group>
<article-title>Impact of weight loss on the metabolic syndrome</article-title>
<source>Diab Obes Metab</source>
<year>2002</year>
<volume>4</volume>
<fpage>407</fpage>
<lpage>414</lpage>
</element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mark</surname><given-names>AL</given-names></name></person-group>
<article-title>Weight reduction for treatment of obesity-associated hypertension: Nuances and challenges</article-title>
<source>Curr Hypertens Rep</source>
<year>2007</year>
<volume>9</volume>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">18177582</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Moore</surname><given-names>TJ</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Vollmer</surname><given-names>WM</given-names></name><name><surname>Svetkey</surname><given-names>LP</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Vogt</surname><given-names>TM</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Windhauser</surname><given-names>MM</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><name><surname>Karanja</surname><given-names>N</given-names></name></person-group>
<article-title>A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group</article-title>
<source>N Engl J Med</source>
<year>1997</year>
<volume>336</volume>
<fpage>1117</fpage>
<lpage>1124</lpage>
<pub-id pub-id-type="pmid">9099655</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>Markandu</surname><given-names>ND</given-names></name><name><surname>Coltart</surname><given-names>R</given-names></name><name><surname>Barron</surname><given-names>J</given-names></name><name><surname>MacGregor</surname><given-names>GA</given-names></name></person-group>
<article-title>Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives</article-title>
<source>Hypertension</source>
<year>2005</year>
<volume>45</volume>
<fpage>571</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">15723964</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jee</surname><given-names>SH</given-names></name><name><surname>Miller</surname><given-names>ER</given-names></name><name><surname>Guallar</surname><given-names>E</given-names></name><name><surname>Singh</surname><given-names>VK</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Klag</surname><given-names>MJ</given-names></name></person-group>
<article-title>The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials</article-title>
<source>Am J Hypertension</source>
<year>2002</year>
<volume>15</volume>
<fpage>691</fpage>
<lpage>696</lpage>
</element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Streppel</surname><given-names>MT</given-names></name><name><surname>Arends</surname><given-names>LR</given-names></name><name><surname>van&#x02019;t Veer</surname><given-names>P</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Gelenijnse</surname><given-names>JM</given-names></name></person-group>
<article-title>Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials</article-title>
<source>Arch Intern Med</source>
<year>2005</year>
<volume>9</volume>
<fpage>95</fpage>
<lpage>97</lpage>
</element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pou</surname><given-names>KM</given-names></name><name><surname>Massaro</surname><given-names>JM</given-names></name><name><surname>Hoffman</surname><given-names>U</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Maurovich-Horvat</surname><given-names>P</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Keaney</surname><given-names>JF</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Lipinska</surname><given-names>I</given-names></name><name><surname>Kathiresen</surname><given-names>S</given-names></name><name><surname>Marabito</surname><given-names>JM</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>CJ</given-names></name><name><surname>Benjaminm</surname><given-names>EJ</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name></person-group>
<article-title>Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study</article-title>
<source>Circulation</source>
<year>2007</year>
<volume>116</volume>
<fpage>1234</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="pmid">17709633</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Guilder</surname><given-names>GP</given-names></name><name><surname>Hoetzer</surname><given-names>?GL</given-names></name><name><surname>Greiner</surname><given-names>JJ</given-names></name><name><surname>Stauffer</surname><given-names>BL</given-names></name><name><surname>Desouza</surname><given-names>CA</given-names></name></person-group>
<article-title>Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults</article-title>
<source>Obesity</source>
<year>2006</year>
<volume>14</volume>
<fpage>2127</fpage>
<lpage>2131</lpage>
<pub-id pub-id-type="pmid">17189537</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vincent</surname><given-names>HK</given-names></name><name><surname>Innes</surname><given-names>KE</given-names></name><name><surname>Vincent</surname><given-names>KR</given-names></name></person-group>
<article-title>Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity</article-title>
<source>Diab Obes Metab</source>
<year>2007</year>
<volume>9</volume>
<fpage>813</fpage>
<lpage>839</lpage>
</element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>MR</given-names></name><name><surname>Gokce</surname><given-names>N</given-names></name></person-group>
<article-title>Endothelial dysfunction in obesity: Etiological role in atherosclerosis</article-title>
<source>Curr Opin Endrocinol Diab Obes</source>
<year>2007</year>
<volume>14</volume>
<fpage>365</fpage>
<lpage>369</lpage>
</element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopes</surname><given-names>HF</given-names></name><name><surname>Martin</surname><given-names>KL</given-names></name><name><surname>Nashar</surname><given-names>K</given-names></name><name><surname>Morrow</surname><given-names>JD</given-names></name><name><surname>Goodfriend</surname><given-names>TL</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name></person-group>
<article-title>DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity</article-title>
<source>Hypertension</source>
<year>2003</year>
<volume>41</volume>
<fpage>422</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">12623938</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>Kumanyika</surname><given-names>SK</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Borhani</surname><given-names>NO</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Langford</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Satterfield</surname><given-names>S</given-names></name><name><surname>Lasser</surname><given-names>NL</given-names></name><name><surname>Cohen</surname><given-names>JD</given-names></name></person-group>
<article-title>Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: Results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Group</article-title>
<source>Am J Clin Nutr</source>
<year>1997</year>
<volume>65</volume>
<issue>Suppl 2</issue>
<fpage>652S</fpage>
<lpage>660S</lpage>
<pub-id pub-id-type="pmid">9022561</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beyer</surname><given-names>FR</given-names></name><name><surname>Dickinson</surname><given-names>HO</given-names></name><name><surname>Nicolson</surname><given-names>DJ</given-names></name><name><surname>Ford</surname><given-names>GA</given-names></name><name><surname>Mason</surname><given-names>J</given-names></name></person-group>
<article-title>Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults</article-title>
<source>Coch Data Sys Rev</source>
<year>2006</year>
<volume>3</volume>
<comment>CDC004805</comment>
</element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grundy</surname><given-names>SM</given-names></name><name><surname>Cleeman</surname><given-names>JI</given-names></name><name><surname>Daniels</surname><given-names>SR</given-names></name><name><surname>Donato</surname><given-names>KA</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Gordon</surname><given-names>DJ</given-names></name><name><surname>Krauss</surname><given-names>RM</given-names></name><name><surname>Savage</surname><given-names>PJ</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><name><surname>Spertus</surname><given-names>JA</given-names></name><name><surname>Costa</surname><given-names>F</given-names></name></person-group>
<article-title>Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</article-title>
<source>Circulation</source>
<year>2005</year>
<volume>112</volume>
<fpage>2735</fpage>
<lpage>2752</lpage>
<pub-id pub-id-type="pmid">16157765</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schakel</surname><given-names>S</given-names></name><name><surname>Buzzard</surname><given-names>I</given-names></name><name><surname>Gebhardt,</surname><given-names>S</given-names></name></person-group>
<article-title>Procedures for estimating nutrient values for food composition databases</article-title>
<source>J Food Comp Anal</source>
<year>1997</year>
<volume>10</volume>
<fpage>102</fpage>
<lpage>114</lpage>
</element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Benedict</surname><given-names>F</given-names></name></person-group>
<article-title>A biometric study of human basal metabolism</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1918</year>
<volume>4</volume>
<fpage>370</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">16576330</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simmons</surname><given-names>SF</given-names></name><name><surname>Reuben</surname><given-names>D</given-names></name></person-group>
<article-title>Nutritional intake monitoring for nursing home residents: A comparison of staff documentation, direct observation, and photography methods</article-title>
<source>J Am Ger Soc</source>
<year>2000</year>
<volume>48</volume>
<fpage>209</fpage>
<lpage>213</lpage>
</element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McVeigh</surname><given-names>GE</given-names></name><name><surname>Bratteli</surname><given-names>CW</given-names></name><name><surname>Morgan</surname><given-names>DJ</given-names></name><name><surname>Alinder</surname><given-names>CM</given-names></name><name><surname>Glasser</surname><given-names>SP</given-names></name><name><surname>Finkelstein</surname><given-names>SM</given-names></name><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group>
<article-title>Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance</article-title>
<source>Hypertension</source>
<year>1999</year>
<volume>33</volume>
<fpage>1392</fpage>
<lpage>1398</lpage>
<pub-id pub-id-type="pmid">10373222</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lemogoum</surname><given-names>D</given-names></name><name><surname>Flores</surname><given-names>G</given-names></name><name><surname>Van den Abeele</surname><given-names>W</given-names></name><name><surname>Ciarka</surname><given-names>A</given-names></name><name><surname>Leeman</surname><given-names>M</given-names></name><name><surname>Dagaute</surname><given-names>JP</given-names></name><name><surname>van de Borne</surname><given-names>P</given-names></name><name><surname>Van Bortel</surname><given-names>L</given-names></name></person-group>
<article-title>Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation</article-title>
<source>J Hypertens</source>
<year>2004</year>
<volume>22</volume>
<fpage>511</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">15076156</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Besch</surname><given-names>W</given-names></name><name><surname>Woltanski</surname><given-names>KP</given-names></name><name><surname>Keilacker</surname><given-names>H</given-names></name><name><surname>Diaz-Alonso</surname><given-names>JM</given-names></name><name><surname>Schulz</surname><given-names>B</given-names></name><name><surname>Amendt</surname><given-names>P</given-names></name><name><surname>Kohnert</surname><given-names>KD</given-names></name><name><surname>Ziegler</surname><given-names>M</given-names></name></person-group>
<article-title>Measurement of insulin in human sera using a new RIA kit, 1: insulin determination in the absence of insulin antibodies&#x02014; conventional assay and micro modification</article-title>
<source>Exp Clin Endocrinol</source>
<year>1987</year>
<volume>90</volume>
<fpage>264</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="pmid">3330034</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><name><surname>Naylor</surname><given-names>BA</given-names></name><name><surname>Treacher</surname><given-names>DF</given-names></name><name><surname>Turner</surname><given-names>RC</given-names></name></person-group>
<article-title>Homeostasis model assessment: insulin resistance and &#x000df;-cell function from fasting plasma glucose and insulin concentrations in man</article-title>
<source>Diabetologia</source>
<year>1985</year>
<volume>28</volume>
<fpage>412</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Bruin</surname><given-names>TW</given-names></name><name><surname>Brouwer</surname><given-names>CB</given-names></name><name><surname>Gimpel</surname><given-names>JA</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name></person-group>
<article-title>Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism</article-title>
<source>Am J Physiol</source>
<year>1991</year>
<volume>260</volume>
<fpage>E492</fpage>
<lpage>E498</lpage>
<pub-id pub-id-type="pmid">1900671</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group>
<article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>
<source>Clin Chem</source>
<year>1972</year>
<volume>18</volume>
<fpage>499</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houston</surname><given-names>MC</given-names></name></person-group>
<article-title>Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension</article-title>
<source>Prog Cardiov Dis</source>
<year>2005</year>
<volume>47</volume>
<fpage>396</fpage>
<lpage>449</lpage>
</element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moline</surname><given-names>J</given-names></name><name><surname>Bukharovich</surname><given-names>IF</given-names></name><name><surname>Wolff</surname><given-names>MS</given-names></name><name><surname>Phillips</surname><given-names>R</given-names></name></person-group>
<article-title>Dietary flavonoids and hypertension: Is there a link?</article-title>
<source>Med Hypoth</source>
<year>2000</year>
<volume>55</volume>
<fpage>306</fpage>
<lpage>309</lpage>
</element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Stamler</surname><given-names>J</given-names></name><name><surname>Nichol</surname><given-names>R</given-names></name><name><surname>Dyer</surname><given-names>AR</given-names></name><name><surname>Stamler</surname><given-names>R</given-names></name><name><surname>Kesteloot</surname><given-names>H</given-names></name><name><surname>Marmot</surname><given-names>M</given-names></name></person-group>
<article-title>Intersalt revisited: Further analyses of 24-hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group</article-title>
<source>Brit Med J</source>
<year>1996</year>
<volume>312</volume>
<fpage>1249</fpage>
<lpage>1253</lpage>
<pub-id pub-id-type="pmid">8634612</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>HO</given-names></name><name><surname>Nicolson</surname><given-names>DJ</given-names></name><name><surname>Cook</surname><given-names>JV</given-names></name><name><surname>Campbell</surname><given-names>F</given-names></name><name><surname>Beyer</surname><given-names>FR</given-names></name><name><surname>Ford</surname><given-names>GA</given-names></name><name><surname>Mason</surname><given-names>J</given-names></name></person-group>
<article-title>Calcium supplementation for the management of primary hypertension in adults</article-title>
<source>Coch Data Sys Rev</source>
<year>2006</year>
<volume>2</volume>
<comment>CD004639</comment>
</element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bucher</surname><given-names>HC</given-names></name><name><surname>Cook</surname><given-names>RJ</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Lang</surname><given-names>JD</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Hatala</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>DL</given-names></name></person-group>
<article-title>Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials</article-title>
<source>JAMA</source>
<year>1996</year>
<volume>275</volume>
<fpage>1016</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="pmid">8596234</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McVeigh</surname><given-names>GE</given-names></name><name><surname>Bratteli</surname><given-names>CW</given-names></name><name><surname>Morgan</surname><given-names>DJ</given-names></name><name><surname>Alinder</surname><given-names>CM</given-names></name><name><surname>Glasser</surname><given-names>SP</given-names></name><name><surname>Finkelstein</surname><given-names>SM</given-names></name><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group>
<article-title>Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance</article-title>
<source>Hypertension</source>
<year>1999</year>
<volume>33</volume>
<fpage>1392</fpage>
<lpage>1398</lpage>
<pub-id pub-id-type="pmid">10373222</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stojiljkovic</surname><given-names>MP</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Lopes</surname><given-names>HF</given-names></name><name><surname>Lee</surname><given-names>CG</given-names></name><name><surname>Goodfriend</surname><given-names>TL</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name></person-group>
<article-title>Hemodynamic effects of lipids in humans</article-title>
<source>Am J Physiol</source>
<year>2001</year>
<volume>R280</volume>
<fpage>1674</fpage>
<lpage>1679</lpage>
</element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davda</surname><given-names>RK</given-names></name><name><surname>Stepniakowski</surname><given-names>KT</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Ullian</surname><given-names>ME</given-names></name><name><surname>Goodfriend</surname><given-names>TL</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name></person-group>
<article-title>Oleic acid inhibits endothelial cell nitric oxide synthase by a PKC-independent mechanism</article-title>
<source>Hypertension</source>
<year>1995</year>
<volume>26</volume>
<fpage>764</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="pmid">7591016</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Greene</surname><given-names>EL</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name></person-group>
<article-title>Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells</article-title>
<source>Hypertension</source>
<year>1998</year>
<volume>32</volume>
<fpage>1003</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="pmid">9856964</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cernes</surname><given-names>R</given-names></name><name><surname>Zimiichman</surname><given-names>R</given-names></name><name><surname>Shargorodsky</surname><given-names>M</given-names></name></person-group>
<article-title>Arterial elasticity in cardiovascular disease: Focus on hypertension, metabolic syndrome and diabetes</article-title>
<source>Adv Cardiol</source>
<year>2008</year>
<volume>45</volume>
<fpage>65</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">18230956</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hansen</surname><given-names>TW</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Thijs</surname><given-names>L</given-names></name><name><surname>Ibsen</surname><given-names>H</given-names></name><name><surname>Jeppesen</surname><given-names>J</given-names></name></person-group>
<article-title>Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population</article-title>
<source>Circulation</source>
<year>2006</year>
<volume>113</volume>
<fpage>664</fpage>
<lpage>670</lpage>
<pub-id pub-id-type="pmid">16461839</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>TT</given-names></name><name><surname>Chiuve</surname><given-names>SE</given-names></name><name><surname>McCullough</surname><given-names>ML</given-names></name><name><surname>Rexrode</surname><given-names>KM</given-names></name><name><surname>Logroscino</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group>
<article-title>Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women</article-title>
<source>Arch Int Med</source>
<year>2008</year>
<volume>168</volume>
<fpage>713</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="pmid">18413553</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name></person-group>
<article-title>Dietary potassium and stroke-associated mortality. A 12-year prospective population study</article-title>
<source>N Engl J Med</source>
<year>1987</year>
<volume>316</volume>
<fpage>235</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="pmid">3796701</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name></person-group>
<article-title>Dietary fiber and reduced ischemic heart disease mortality rates in men and women: A 12-year prospective study</article-title>
<source>Am J Epidemiol</source>
<year>1987</year>
<volume>126</volume>
<fpage>1093</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="pmid">2825519</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garside</surname><given-names>PS</given-names></name><name><surname>Gleuck</surname><given-names>CJ</given-names></name></person-group>
<article-title>The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: The prospective NHANES I follow-up study</article-title>
<source>J Am Coll Nutr</source>
<year>1995</year>
<volume>14</volume>
<fpage>71</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">7706615</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Djouss&#x000e9;</surname><given-names>L</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Ellison</surname><given-names>RC</given-names></name></person-group>
<article-title>Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study</article-title>
<source>Hypertension</source>
<year>2005</year>
<volume>45</volume>
<fpage>368</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="pmid">15655119</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Preli</surname><given-names>RB</given-names></name><name><surname>Klein</surname><given-names>KP</given-names></name><name><surname>Herrington</surname><given-names>DM</given-names></name></person-group>
<article-title>Vascular effects of dietary L-arginine supplementation</article-title>
<source>Atherosclerosis</source>
<year>2002</year>
<volume>162</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">11947892</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lekakis</surname><given-names>JP</given-names></name><name><surname>Papathanassiou</surname><given-names>S</given-names></name><name><surname>Papaioannou</surname><given-names>TG</given-names></name><name><surname>Papamichael</surname><given-names>CM</given-names></name><name><surname>Zakopoulos</surname><given-names>N</given-names></name><name><surname>Kotsis</surname><given-names>V</given-names></name><name><surname>Dagre</surname><given-names>AG</given-names></name><name><surname>Stamatelopoulos</surname><given-names>K</given-names></name><name><surname>Protogerou</surname><given-names>A</given-names></name><name><surname>Stamatelopoulos</surname><given-names>SF</given-names></name></person-group>
<article-title>Oral L-arginine improves endothelial dysfunction in patients with essential hypertension</article-title>
<source>Int J Cardiol</source>
<year>2002</year>
<volume>86</volume>
<fpage>317</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">12419572</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castejon</surname><given-names>AM</given-names></name><name><surname>Hoffmann</surname><given-names>IS</given-names></name><name><surname>Jimenez</surname><given-names>E</given-names></name><name><surname>Cubeddu</surname><given-names>RJ</given-names></name><name><surname>Baldonedo</surname><given-names>RM</given-names></name><name><surname>Cubeddu</surname><given-names>LX</given-names></name></person-group>
<article-title>Comparative effects of L-arginine infusion in obese hypertensive and lean normotensive: Blood pressure, heart rate and insulin levels</article-title>
<source>J Hum Hypertens</source>
<year>2002</year>
<volume>16</volume>
<issue>Suppl 1</issue>
<fpage>S33</fpage>
<lpage>S36</lpage>
</element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Engelhard</surname><given-names>YN</given-names></name><name><surname>Gazer</surname><given-names>B</given-names></name><name><surname>Paran</surname><given-names>E</given-names></name></person-group>
<article-title>Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double-blind, placebo-controlled pilot study</article-title>
<source>Am Heart J</source>
<year>2006</year>
<volume>151</volume>
<fpage>100</fpage>
<comment>(abstract)</comment>
<pub-id pub-id-type="pmid">16368299</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ward</surname><given-names>NC</given-names></name><name><surname>Hodgson</surname><given-names>JM</given-names></name><name><surname>Croft</surname><given-names>KD</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Puddey</surname><given-names>IB</given-names></name></person-group>
<article-title>The combination of vitamin C and grape-seed polyphenols increases blood pressure: A randomized, double-blind, placebo-controlled trial</article-title>
<source>J Hypertens</source>
<year>2005</year>
<volume>23</volume>
<fpage>427</fpage>
<lpage>434</lpage>
<pub-id pub-id-type="pmid">15662232</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Uscio</surname><given-names>LV</given-names></name><name><surname>Milstein</surname><given-names>S</given-names></name><name><surname>Richardson</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Katusic</surname><given-names>ZS</given-names></name></person-group>
<article-title>Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity</article-title>
<source>Circ Res</source>
<year>2003</year>
<volume>92</volume>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">12522125</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nosratola</surname><given-names>D</given-names></name><name><surname>Vaziri</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>XQ</given-names></name><name><surname>Oveisi</surname><given-names>F</given-names></name><name><surname>Rad</surname><given-names>B</given-names></name></person-group>
<article-title>Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats</article-title>
<source>Hypertension</source>
<year>2000</year>
<volume>36</volume>
<fpage>142</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="pmid">10904027</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plantinga</surname><given-names>Y</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Magagna</surname><given-names>A</given-names></name><name><surname>Giannarelli</surname><given-names>C</given-names></name><name><surname>Franzoni</surname><given-names>F</given-names></name><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group>
<article-title>Supplementation with Vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients</article-title>
<source>Am J Hypertens</source>
<year>2007</year>
<volume>20</volume>
<fpage>392</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">17386345</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heller</surname><given-names>R</given-names></name><name><surname>Werner-Felmayer</surname><given-names>G</given-names></name><name><surname>Werner</surname><given-names>ER</given-names></name></person-group>
<article-title>Alpha-tocopherol and endothelial nitric oxide synthesis</article-title>
<source>Ann NY Acad Sci</source>
<year>2004</year>
<volume>1031</volume>
<fpage>74</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">15753135</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ward</surname><given-names>NC</given-names></name><name><surname>Wu</surname><given-names>JHY</given-names></name><name><surname>Clarke</surname><given-names>MW</given-names></name><name><surname>Puddey</surname><given-names>IB</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Croft</surname><given-names>KD</given-names></name><name><surname>Hodgson</surname><given-names>JM</given-names></name></person-group>
<article-title>The effect of vitamin E on blood pressure in individuals with type 2 diabetes: A randomized,double-blind, placebo-controlled trial</article-title>
<source>J Hypertens</source>
<year>2007</year>
<volume>25</volume>
<fpage>227</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="pmid">17143195</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Etten</surname><given-names>RW</given-names></name><name><surname>de Koning</surname><given-names>EJ</given-names></name><name><surname>Verhaar</surname><given-names>MC</given-names></name><name><surname>Gaillard</surname><given-names>CA</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name></person-group>
<article-title>Impaired NO-dependent vasodilation in patients with type II (non&#x02014;insulin-dependent) diabetes mellitus is restored by acute administration of folate</article-title>
<source>Diabetologia</source>
<year>2002</year>
<volume>45</volume>
<fpage>1004</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="pmid">12136399</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>RA</given-names></name><name><surname>Rauwerda</surname><given-names>JA</given-names></name><name><surname>Steyn</surname><given-names>M</given-names></name><name><surname>Twisk</surname><given-names>JW</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name></person-group>
<article-title>Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2001</year>
<volume>21</volume>
<fpage>2072</fpage>
<lpage>2079</lpage>
<pub-id pub-id-type="pmid">11742887</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Forman</surname><given-names>JP</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Curhan</surname><given-names>GC</given-names></name></person-group>
<article-title>Folate intake and the risk of incident hypertension among US women</article-title>
<source>JAMA</source>
<year>2005</year>
<volume>293</volume>
<fpage>320</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="pmid">15657325</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doshi</surname><given-names>SN</given-names></name><name><surname>McDowell</surname><given-names>IF</given-names></name><name><surname>Moat</surname><given-names>SJ</given-names></name><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>Newcombe</surname><given-names>RG</given-names></name><name><surname>Kredan</surname><given-names>MB</given-names></name><name><surname>Lewis</surname><given-names>MJ</given-names></name><name><surname>Goodfellow</surname><given-names>J</given-names></name></person-group>
<article-title>Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2001</year>
<volume>21</volume>
<fpage>1196</fpage>
<lpage>1202</lpage>
<pub-id pub-id-type="pmid">11451751</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verhaar</surname><given-names>MC</given-names></name><name><surname>Wever</surname><given-names>RM</given-names></name><name><surname>Kastelein</surname><given-names>JJ</given-names></name><name><surname>van Dam</surname><given-names>T</given-names></name><name><surname>Koomans</surname><given-names>HA</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name></person-group>
<article-title>5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia</article-title>
<source>Circulation</source>
<year>1998</year>
<volume>97</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="pmid">9462523</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>The study flow diagram shows the number of obese and lean volunteers that were screened, met inclusion and exclusion criteria, and completed the three dietary periods</p></caption><graphic xlink:href="nihms-111567-f0001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Peripheral (brachial cuff [left]) and central (right) systolic (top) and diastolic (bottom) blood pressures are provided for the obese hypertensive [ &#x025cf;] and lean volunteers [&#x025b2;] on the three dietary periods. Values reflect the means and standard error of multiple baseline, supine readings after three weeks on each diet. ULFV = usual diet low in fruits and vegetables; ULFV-S = usual diet supplemented with potassium, magnesium and fiber to match DASH; DASH = high fruits and vegetables DASH. * p&#x0003c;0.05, ** p&#x0003c;0.01, *** p&#x0003c;0.001 DASH vs ULFV; <bold>+</bold> p&#x0003c;0.05 DASH vs ULFV-S. P-values refer to comparisons within the obese group only as none of the blood pressure values among the three diets was significantly different in lean normotensives.</p></caption><graphic xlink:href="nihms-111567-f0002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>The differences in mean (&#x000b1; standard error) baseline supine blood pressures after three weeks are shown for systolic (dark bars) and diastolic BP (light bars) on ULFV (L) vs. DASH ([D] left), ULFV (U) vs. ULFV-S ([U-S] middle) and ULFV-S vs. DASH ([U-S/D] right) for both obese hypertensives (top) and lean normotensives (bottom). * p&#x0003c;0.05, *** p&#x0003c;0.001 DASH (D) vs ULFV (U); <bold>++</bold> p&#x0003c;0.01 DASH (D) vs ULFV-S (U-S).</p></caption><graphic xlink:href="nihms-111567-f0003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Small (top panel) and large (middle panel) artery elasticity indices and aortic augmentation index (bottom panel) are shown for obese hypertensives [ &#x025cf; ] and lean normotensives [&#x025b2;]. * p&#x0003c;0.05, ** p&#x0003c;0.01, *** p&#x0003c;0.001 DASH vs ULFV; <bold>+</bold> p&#x0003c;0.05 DASH vs ULFV-S; <bold>&#x003b7;</bold> p&#x0003c;0.001 ULFV-S vs ULFV. P-values are for within group comparisons.</p></caption><graphic xlink:href="nihms-111567-f0004"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Selected baseline descriptive characteristics (mean &#x000b1; SEM) of obese hypertensive and lean normotensive volunteers.</p></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Variables</th><th align="left" valign="middle" rowspan="1" colspan="1">Obese Hypertensives</th><th align="left" valign="middle" rowspan="1" colspan="1">Lean Normotensives</th><th align="center" valign="middle" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age , years</td><td align="left" valign="middle" rowspan="1" colspan="1">40.3 &#x000b1; 1.7</td><td align="left" valign="middle" rowspan="1" colspan="1">36.7 &#x000b1; 1.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gender, F/M</td><td align="left" valign="middle" rowspan="1" colspan="1">12 F/ 3 M</td><td align="left" valign="middle" rowspan="1" colspan="1">12 F/ 3 M</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race, black/white</td><td align="left" valign="middle" rowspan="1" colspan="1">8 B/7 W</td><td align="left" valign="middle" rowspan="1" colspan="1">5 B / 10 W</td><td align="center" valign="middle" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Systolic BP, mm Hg</td><td align="left" valign="middle" rowspan="1" colspan="1">136.3 &#x000b1; 1.1</td><td align="left" valign="middle" rowspan="1" colspan="1">110.4 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diastolic BP, mm Hg</td><td align="left" valign="middle" rowspan="1" colspan="1">88.6 &#x000b1; 0.9</td><td align="left" valign="middle" rowspan="1" colspan="1">70.0 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">34.5 &#x000b1; 1.3</td><td align="left" valign="middle" rowspan="1" colspan="1">22.8 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Abdominal girth, in</td><td align="left" valign="middle" rowspan="1" colspan="1">41.4 &#x000b1; 1.1</td><td align="left" valign="middle" rowspan="1" colspan="1">31.7 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hip circumference, in</td><td align="left" valign="middle" rowspan="1" colspan="1">46.9 &#x000b1; 1.2</td><td align="left" valign="middle" rowspan="1" colspan="1">38.3 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total Chol, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">188 &#x000b1; 11</td><td align="left" valign="middle" rowspan="1" colspan="1">187 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDL-C, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">47.0 &#x000b1; 3.1</td><td align="left" valign="middle" rowspan="1" colspan="1">58.9 &#x000b1; 4.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Triglycerides, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">92 &#x000b1; 10</td><td align="left" valign="middle" rowspan="1" colspan="1">57 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDL-C, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">122 &#x000b1; 9</td><td align="left" valign="middle" rowspan="1" colspan="1">117 &#x000b1; 5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucose, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">96.1 &#x000b1; 1.9</td><td align="left" valign="middle" rowspan="1" colspan="1">86.5 &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sodium, mmol/L</td><td align="left" valign="middle" rowspan="1" colspan="1">138.9 &#x000b1; 0.5</td><td align="left" valign="middle" rowspan="1" colspan="1">138.5 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Potassium, mmol/L</td><td align="left" valign="middle" rowspan="1" colspan="1">4.2 &#x000b1; 0.1</td><td align="left" valign="middle" rowspan="1" colspan="1">4.4 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Creatinine, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">0.83 &#x000b1; 0.04</td><td align="left" valign="middle" rowspan="1" colspan="1">0.79 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Calcium, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">9.4 &#x000b1; 0.1</td><td align="left" valign="middle" rowspan="1" colspan="1">9.4 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Phosphorus, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">3.6 &#x000b1; 0.2</td><td align="left" valign="middle" rowspan="1" colspan="1">3.5 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Uric acid, mg/dL</td><td align="left" valign="middle" rowspan="1" colspan="1">5.1 &#x000b1; 0.2</td><td align="left" valign="middle" rowspan="1" colspan="1">3.9 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p>The nutrient goal and mean daily intake in all subjects combined for ULFV, ULFV-S, and DASH. Values are expressed as mean &#x000b1; SEM.</p></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="left" valign="middle" colspan="1">Nutrients (units)</th><th colspan="6" align="left" valign="middle" rowspan="1">All Subjects</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Goal<break/>ULFV</th><th align="left" valign="middle" rowspan="1" colspan="1">Actual<break/>ULFV</th><th align="left" valign="middle" rowspan="1" colspan="1">Goal<break/>ULFV-S</th><th align="left" valign="middle" rowspan="1" colspan="1">Actual<break/>ULFV-S</th><th align="left" valign="middle" rowspan="1" colspan="1">Goal<break/>DASH</th><th align="left" valign="middle" rowspan="1" colspan="1">Actual<break/>DASH</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fruit, N/day</td><td align="left" valign="middle" rowspan="1" colspan="1">1-2</td><td align="left" valign="middle" rowspan="1" colspan="1">0.9 &#x000b1; 0.8<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">1-2</td><td align="left" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.8</td><td align="left" valign="middle" rowspan="1" colspan="1">5-6</td><td align="left" valign="middle" rowspan="1" colspan="1">4.5 &#x000b1; 1.5<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Veg, N/day</td><td align="left" valign="middle" rowspan="1" colspan="1">1-2</td><td align="left" valign="middle" rowspan="1" colspan="1">1.1 &#x000b1; 0.6<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">1-2</td><td align="left" valign="middle" rowspan="1" colspan="1">1.1 &#x000b1; 0.8</td><td align="left" valign="middle" rowspan="1" colspan="1">3-4</td><td align="left" valign="middle" rowspan="1" colspan="1">3.3 &#x000b1; 1.5<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Kcals/day</td><td align="left" valign="middle" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" rowspan="1" colspan="1">1920 &#x000b1; 43<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" rowspan="1" colspan="1">1991 &#x000b1; 50</td><td align="left" valign="middle" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" rowspan="1" colspan="1">2201 &#x000b1; 44<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Protein, % kcal</td><td align="left" valign="middle" rowspan="1" colspan="1">15</td><td align="left" valign="middle" rowspan="1" colspan="1">15.9 &#x000b1; 0.3<xref ref-type="table-fn" rid="TFN5">#</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">15</td><td align="left" valign="middle" rowspan="1" colspan="1">14.9 &#x000b1; 0.4</td><td align="left" valign="middle" rowspan="1" colspan="1">15</td><td align="left" valign="middle" rowspan="1" colspan="1">14.7 &#x000b1; 0.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carb, % kcals</td><td align="left" valign="middle" rowspan="1" colspan="1">50</td><td align="left" valign="middle" rowspan="1" colspan="1">45.8 &#x000b1; 0.8<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">50</td><td align="left" valign="middle" rowspan="1" colspan="1">48.5 &#x000b1; 0.8<xref ref-type="table-fn" rid="TFN3">+</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">50</td><td align="left" valign="middle" rowspan="1" colspan="1">51.2 &#x000b1; 0.8<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fat, % kcals</td><td align="left" valign="middle" rowspan="1" colspan="1">35</td><td align="left" valign="middle" rowspan="1" colspan="1">37.7 &#x000b1; 0.7<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">35</td><td align="left" valign="middle" rowspan="1" colspan="1">35.4 &#x000b1; 0.7<xref ref-type="table-fn" rid="TFN3">+</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">35</td><td align="left" valign="middle" rowspan="1" colspan="1">33.3 &#x000b1; 0.7<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Alcohol, % kcals</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">0.7 &#x000b1; 0.2</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">1.3 &#x000b1; 0.3</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chol, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">300</td><td align="left" valign="middle" rowspan="1" colspan="1">327 &#x000b1; 17<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">300</td><td align="left" valign="middle" rowspan="1" colspan="1">297 &#x000b1; 15</td><td align="left" valign="middle" rowspan="1" colspan="1">300</td><td align="left" valign="middle" rowspan="1" colspan="1">260 &#x000b1; 14</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">K<sup>+</sup>, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">1700</td><td align="left" valign="middle" rowspan="1" colspan="1">1861 &#x000b1; 46<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003e;4100</td><td align="left" valign="middle" rowspan="1" colspan="1">3888 &#x000b1; 80<xref ref-type="table-fn" rid="TFN4">++</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003e;4100</td><td align="left" valign="middle" rowspan="1" colspan="1">3768 &#x000b1; 80</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fiber, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">9</td><td align="left" valign="middle" rowspan="1" colspan="1">11.9 &#x000b1; 0.4<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">31.0</td><td align="left" valign="middle" rowspan="1" colspan="1">25.4 &#x000b1; 0.5<xref ref-type="table-fn" rid="TFN4">++</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">31.0</td><td align="left" valign="middle" rowspan="1" colspan="1">28.2 &#x000b1; 0.8<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Na<sup>+</sup>, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">3000</td><td align="left" valign="middle" rowspan="1" colspan="1">3603 &#x000b1; 103</td><td align="left" valign="middle" rowspan="1" colspan="1">3000</td><td align="left" valign="middle" rowspan="1" colspan="1">3736 &#x000b1; 90</td><td align="left" valign="middle" rowspan="1" colspan="1">3000</td><td align="left" valign="middle" rowspan="1" colspan="1">3613 &#x000b1; 101</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mg<sup>++</sup>, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">175</td><td align="left" valign="middle" rowspan="1" colspan="1">194 &#x000b1; 5<xref ref-type="table-fn" rid="TFN6">##</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">500</td><td align="left" valign="middle" rowspan="1" colspan="1">445 &#x000b1; 16<sup>+++</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">500</td><td align="left" valign="middle" rowspan="1" colspan="1">401 &#x000b1; 10<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ca<sup>++</sup>, mg/d</td><td align="left" valign="middle" rowspan="1" colspan="1">700</td><td align="left" valign="middle" rowspan="1" colspan="1">672 &#x000b1; 29<xref ref-type="table-fn" rid="TFN5">#</xref></td><td align="left" valign="middle" rowspan="1" colspan="1">700</td><td align="left" valign="middle" rowspan="1" colspan="1">688 &#x000b1; 26</td><td align="left" valign="middle" rowspan="1" colspan="1">700</td><td align="left" valign="middle" rowspan="1" colspan="1">763 &#x000b1; 27</td></tr></tbody></table><table-wrap-foot><p>Veg, = vegetables; N/day = servings per day; Kcal = 1000 calories or 1 Calorie, % kcal = % of total daily calories; Carb = carbohydrate.</p><fn id="TFN1"><label>*</label><p id="P43">indicate that ULFV-S and DASH are different at p&#x0003c;0.05</p></fn><fn id="TFN2"><label>**</label><p id="P44">p&#x0003c;0.01, respectively.</p></fn><fn id="TFN3"><label>+</label><p id="P45">indicate that ULFV-S and ULFV are different at p&#x0003c;0.05</p></fn><fn id="TFN4"><label>++</label><p id="P46">p&#x0003c;0.01, respectively.</p></fn><fn id="TFN5"><label>#</label><p id="P47">indicate that DASH and ULFV are different at p&#x0003c; 0.05</p></fn><fn id="TFN6"><label>##</label><p id="P48">p&#x0003c; 0.01, respectively.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Nutrient intake (mean &#x000b1; SEM) is shown for obese hypertensives on ULFV-S and DASH.</p></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Nutrient intake</th><th align="center" valign="middle" rowspan="1" colspan="1">ULFV-S</th><th align="center" valign="middle" rowspan="1" colspan="1">DASH</th><th align="center" valign="middle" rowspan="1" colspan="1">Mean Change<break/>DASH&#x02014;ULFV-S</th><th align="center" valign="middle" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Na<sup>+</sup>, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">3854&#x000b1;185</td><td align="center" valign="middle" rowspan="1" colspan="1">3563&#x000b1;231</td><td align="center" valign="middle" rowspan="1" colspan="1">-291 &#x000b1; 183</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K<sup>+</sup>, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">3791 &#x000b1; 227</td><td align="center" valign="middle" rowspan="1" colspan="1">3873 &#x000b1; 241</td><td align="center" valign="middle" rowspan="1" colspan="1">83 &#x000b1; 193</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ca<sup>++</sup>, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">666 &#x000b1; 56</td><td align="center" valign="middle" rowspan="1" colspan="1">807 &#x000b1; 46</td><td align="center" valign="middle" rowspan="1" colspan="1">141 &#x000b1; 72</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mg<sup>++</sup>, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">455 &#x000b1; 35</td><td align="center" valign="middle" rowspan="1" colspan="1">410 &#x000b1; 27</td><td align="center" valign="middle" rowspan="1" colspan="1">-45 &#x000b1; 29</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lycopene, mcg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">3125 &#x000b1; 791</td><td align="center" valign="middle" rowspan="1" colspan="1">6546 &#x000b1; 1213</td><td align="center" valign="middle" rowspan="1" colspan="1">3422 &#x000b1;1313</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Selenium, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">285 &#x000b1; 159</td><td align="center" valign="middle" rowspan="1" colspan="1">126 &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1">-159 &#x000b1; 159</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">44 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">216 &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1">172 &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vitamin E, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">8.3 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">14.8 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">6.5 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alpha Vit E, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Beta Vit E, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.29 &#x000b1; 0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Folate, &#x003bc;g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">488 &#x000b1; 30</td><td align="center" valign="middle" rowspan="1" colspan="1">666 &#x000b1; 40</td><td align="center" valign="middle" rowspan="1" colspan="1">178 &#x000b1; 35</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arginine, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">5.1 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arachidonic Acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14 &#x000b1; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Linoleic Acid, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">14.1 &#x000b1; 1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">16.1 &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Linolenic, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DHA, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17 &#x000b1; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18 &#x000b1; 0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01 &#x000b1; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">EPA, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#x000b1; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0.73</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Total trans fat, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">6.3 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Insoluble Fiber, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">11.1 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">19.2 &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">8.5 &#x000b1; 1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Soluble Fiber, g/d</td><td align="center" valign="middle" rowspan="1" colspan="1">14.3 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">8.5 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-5.8 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;.0001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Caffeine, mg/d</td><td align="center" valign="middle" rowspan="1" colspan="1">78 &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1">67 &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">11 &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.50</td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float" orientation="landscape"><label>Table 4</label><caption><p>Selected metabolic and urine electrolyte data are shown for lean normotensive subjects (top) and obese hypertensives (bottom) on the three dietary periods.</p></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="left" valign="top" colspan="1"/><th colspan="3" align="center" valign="top" rowspan="1">Lean Normotensive Volunteers</th><th colspan="3" align="center" valign="top" rowspan="1">Obese Hypertensive Subjects</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">ULFV</th><th align="center" valign="top" rowspan="1" colspan="1">DASH</th><th align="center" valign="top" rowspan="1" colspan="1">ULFV-S</th><th align="center" valign="top" rowspan="1" colspan="1">ULFV</th><th align="center" valign="top" rowspan="1" colspan="1">DASH</th><th align="center" valign="top" rowspan="1" colspan="1">ULFV-S</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight, pounds</td><td align="center" valign="top" rowspan="1" colspan="1">141.4 &#x000b1; 5.0</td><td align="center" valign="top" rowspan="1" colspan="1">143.9 &#x000b1; 5.1</td><td align="center" valign="top" rowspan="1" colspan="1">142.3 &#x000b1; 5.0</td><td align="center" valign="top" rowspan="1" colspan="1">210.7 &#x000b1; 8.1</td><td align="center" valign="top" rowspan="1" colspan="1">210.1 &#x000b1; 7.8</td><td align="center" valign="top" rowspan="1" colspan="1">211 &#x000b1; 8.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HR, beats/min</td><td align="center" valign="top" rowspan="1" colspan="1">64.5 &#x000b1; 1.2</td><td align="center" valign="top" rowspan="1" colspan="1">66.3 &#x000b1; 1.4</td><td align="center" valign="top" rowspan="1" colspan="1">64.8 &#x000b1; 1.3</td><td align="center" valign="top" rowspan="1" colspan="1">68.9 &#x000b1; 0.9</td><td align="center" valign="top" rowspan="1" colspan="1">68.2 &#x000b1; 1.0</td><td align="center" valign="top" rowspan="1" colspan="1">70.1 &#x000b1; 1.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insulin, &#x003bc;U/mL</td><td align="center" valign="top" rowspan="1" colspan="1">5.2 &#x000b1; 0.7</td><td align="center" valign="top" rowspan="1" colspan="1">6.0 &#x000b1; 1.0</td><td align="center" valign="top" rowspan="1" colspan="1">6.0 &#x000b1; 0.9</td><td align="center" valign="top" rowspan="1" colspan="1">12.4 &#x000b1; 1.5</td><td align="center" valign="top" rowspan="1" colspan="1">14.1 &#x000b1; 1.6</td><td align="center" valign="top" rowspan="1" colspan="1">18.2 &#x000b1; 6.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glucose, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">82.4 &#x000b1; 2</td><td align="center" valign="top" rowspan="1" colspan="1">81.8 &#x000b1; 1.9</td><td align="center" valign="top" rowspan="1" colspan="1">84.3 &#x000b1; 1.7</td><td align="center" valign="top" rowspan="1" colspan="1">87.4 &#x000b1; 2.2</td><td align="center" valign="top" rowspan="1" colspan="1">88.5 &#x000b1; 1.7</td><td align="center" valign="top" rowspan="1" colspan="1">81.9 &#x000b1; 5.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HOMAir</td><td align="center" valign="top" rowspan="1" colspan="1">1.0 &#x000b1; 0.1</td><td align="center" valign="top" rowspan="1" colspan="1">1.2 &#x000b1; 0.2</td><td align="center" valign="top" rowspan="1" colspan="1">1.3 &#x000b1; 0.2</td><td align="center" valign="top" rowspan="1" colspan="1">2.72 &#x000b1; 0.3</td><td align="center" valign="top" rowspan="1" colspan="1">3.03 &#x000b1; 0.3</td><td align="center" valign="top" rowspan="1" colspan="1">2.6 &#x000b1; 0.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cholesterol, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">169 &#x000b1; 7</td><td align="center" valign="top" rowspan="1" colspan="1">162 &#x000b1;12</td><td align="center" valign="top" rowspan="1" colspan="1">158 &#x000b1; 10</td><td align="center" valign="top" rowspan="1" colspan="1">177 &#x000b1; 10</td><td align="center" valign="top" rowspan="1" colspan="1">167 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">165 &#x000b1; 8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TG, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">47 &#x000b1; 5</td><td align="center" valign="top" rowspan="1" colspan="1">49 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">56 &#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">91.3 &#x000b1; 12.6</td><td align="center" valign="top" rowspan="1" colspan="1">80.4 &#x000b1; 9.7</td><td align="center" valign="top" rowspan="1" colspan="1">85.2 &#x000b1; 14.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">106 &#x000b1; 5</td><td align="center" valign="top" rowspan="1" colspan="1">110 &#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">106&#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">116.7 &#x000b1; 8.2</td><td align="center" valign="top" rowspan="1" colspan="1">109.7 &#x000b1; 6.8</td><td align="center" valign="top" rowspan="1" colspan="1">108.2 &#x000b1; 6.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">54 &#x000b1; 4</td><td align="center" valign="top" rowspan="1" colspan="1">53 &#x000b1; 3</td><td align="center" valign="top" rowspan="1" colspan="1">53 &#x000b1; 4</td><td align="center" valign="top" rowspan="1" colspan="1">42.2 &#x000b1; 2.8</td><td align="center" valign="top" rowspan="1" colspan="1">40.5 &#x000b1; 2.63</td><td align="center" valign="top" rowspan="1" colspan="1">40.6 &#x000b1; 2.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VLDL, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">9.4 &#x000b1; 1.0</td><td align="center" valign="top" rowspan="1" colspan="1">9.8 &#x000b1; 1.7</td><td align="center" valign="top" rowspan="1" colspan="1">10.8 &#x000b1; 1.3</td><td align="center" valign="top" rowspan="1" colspan="1">18.1 &#x000b1; 2.5</td><td align="center" valign="top" rowspan="1" colspan="1">16.7 &#x000b1; 1.8</td><td align="center" valign="top" rowspan="1" colspan="1">17.0 &#x000b1; 2.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Urine Na<sup>+</sup>, mmol/d</td><td align="center" valign="top" rowspan="1" colspan="1">97 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">93 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">103 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">108 &#x000b1; 10</td><td align="center" valign="top" rowspan="1" colspan="1">98 &#x000b1; 7</td><td align="center" valign="top" rowspan="1" colspan="1">102 &#x000b1; 7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Urine K<sup>+</sup>, mmol/d</td><td align="center" valign="top" rowspan="1" colspan="1">31 &#x000b1; 2<xref ref-type="table-fn" rid="TFN7">&#x003a9;</xref>,<xref ref-type="table-fn" rid="TFN9">&#x003a6;&#x003a6;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">41 &#x000b1; 3</td><td align="center" valign="top" rowspan="1" colspan="1">47 &#x000b1; 4</td><td align="center" valign="top" rowspan="1" colspan="1">32 &#x000b1; 3<xref ref-type="table-fn" rid="TFN7">&#x003a9;</xref>, <xref ref-type="table-fn" rid="TFN9">&#x003a6;&#x003a6;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">46 &#x000b1; 5</td><td align="center" valign="top" rowspan="1" colspan="1">51 &#x000b1; 5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Urine Mg<sup>++</sup>, mg/d</td><td align="center" valign="top" rowspan="1" colspan="1">56 &#x000b1; 5<xref ref-type="table-fn" rid="TFN7">&#x003a9;</xref>,<xref ref-type="table-fn" rid="TFN8">&#x003a6;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">67 &#x000b1; 8</td><td align="center" valign="top" rowspan="1" colspan="1">69 &#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">57 &#x000b1; 5<xref ref-type="table-fn" rid="TFN8">&#x003a6;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">63 &#x000b1; 6</td><td align="center" valign="top" rowspan="1" colspan="1">66 &#x000b1; 6</td></tr></tbody></table><table-wrap-foot><p>HOMAir = homeostatic model assessment of insulin resistance</p><p>Chol = cholesterol; TG = triglycerides, LDL = low-density lipoprotein cholesterol; HDL &#x02014; high-density lipoprotein cholesterol; VLDL = very low-density lipoprotein cholesterol; Na<sup>+</sup> = sodium; K<sup>+</sup> = potassium; Mg<sup>++</sup> = magnesium.</p><fn id="TFN7"><label>&#x003a9;</label><p id="P49">p&#x0003c;0.05 vs DASH</p></fn><fn id="TFN8"><label>&#x003a6;</label><p id="P50">p&#x0003c;0.05 vs ULFV-S</p></fn><fn id="TFN9"><label>&#x003a6;&#x003a6;</label><p id="P51">p&#x0003c;0.01 vs ULFV-S within the lean normotensive and obese hypertensive groups</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Summary.</p></caption><table frame="void" rules="none"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold><underline>What is known about topic</underline></bold>:</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02022; The high fruits and vegetables DASH Eating Plan lowers blood pressure and improves markers endothelial function in obese subjects with the metabolic syndrome and elevated blood pressures, but it is not clear whether this effect reflects the favorable mineral and fiber composition or other components of whole foods.</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold><underline>What this study adds</underline></bold>:</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02022; The high fruits and vegetables Eating Plan lowers blood pressure and improves markers of endothelial function more in abdominally obese subjects with elevated blood pressures than an isocaloric diet with comparable sodium and calcium content that is supplemented with potassium, magnesium and fiber to match DASH. Thus, components of whole foods appear to mediate the beneficial effects of DASH on blood pressure and vascular function beyond or in addition to their mineral and fiber content.</td></tr></tbody></table></table-wrap></floats-group></article>